Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | APLP2 |
| Upstream (Parents) |
|---|
| (<<) DHX9 → APLP2 |
| (<<) EIF5B → APLP2 |
| (<<) SYNJ1 → APLP2 |
| (<<) ATP13A3 → APLP2 |
| Downstream (Children) |
|---|
| APLP2 → PYGO1 (>>) |
| APLP2 → RPAIN (>>) |
| APLP2 → GJB3 (>>) |
| APLP2 → GTF2A1 (>>) |
| APLP2 → FER1L4 (>>) |
| APLP2 → TAS2R4 (>>) |
| APLP2 → RBM12B (>>) |
| APLP2 → TEP1 (>>) |
| APLP2 → DVL3 (>>) |
| APLP2 → RRP8 (>>) |
| APLP2 → RAB3GAP2 (>>) |
| APLP2 → DHX9 (>>) |
| APLP2 → EIF5B (>>) |
| APLP2 → C10orf110 (>>) |
| APLP2 → TLK1 (>>) |
| APLP2 → BMP8A///BMP8B (>>) |
| APLP2 → SYNJ1 (>>) |
| APLP2 → NUCKS1 (>>) |
| APLP2 → ZNF434 (>>) |
